Everence Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,650
| Closed | -$122K | – | 997 |
|
|
2024
Q3 | $122K | Buy |
11,650
+200
| +2% | +$2.09K | 0.01% | 740 |
|
|
2024
Q2 | $176 | Hold |
11,450
| – | – | 0.01% | 701 |
|
|
2024
Q1 | $241 | Hold |
11,450
| – | – | 0.02% | 652 |
|
|
2023
Q4 | $206K | Hold |
11,450
| – | – | 0.01% | 696 |
|
|
2023
Q3 | $188 | Buy |
+11,450
| New | +$188 | 0.01% | 683 |
|
|
2021
Q4 | – | Sell |
-5,140
| Closed | -$215K | – | 791 |
|
|
2021
Q3 | $215K | Buy |
+5,140
| New | +$215K | 0.02% | 673 |
|
|
2021
Q1 | – | Sell |
-5,140
| Closed | -$233K | – | 735 |
|
|
2020
Q4 | $233K | Buy |
+5,140
| New | +$233K | 0.02% | 604 |
|